neostigmine has been researched along with Autoimmune Disease in 22 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of intranasally administered neostigmine was tested in 22 patients with generalized myasthenia gravis (MG)." | 5.07 | Efficacy of intranasal administration of neostigmine in myasthenic patients. ( Benvenuti, C; Cei, G; Cornelio, F; Cosi, V; Lombardi, M; Nicora, M; Pareyson, D; Ricciardi, R; Sghirlanzoni, A, 1992) |
| " C57BL/6 mice were inoculated with Torpedo acetylcholine receptors (T-AChR) emulsified in Titermax (TM), an adjuvant containing nonionic block copolymer and no microbial products, and evaluated for experimental autoimmune myasthenia gravis (EAMG) susceptibility." | 3.68 | Induction of experimental autoimmune myasthenia gravis with acetylcholine receptors using a nonionic block copolymer as adjuvant. ( Christadoss, P; Shenoy, M, 1993) |
| "Patients with myasthenia gravis (MG) have increased tolerance to the neuromuscular blocking properties of suxamethonium (SCh) and decamethonium (C10) and exhibit a reversal of the C10-induced block by neostigmine." | 3.66 | Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle. ( Johnson, BR; Kim, YI; Sanders, DB, 1983) |
| "This congenital myasthenic syndrome is for the first time associated with an autosomal translocation 2q31-9p27." | 1.31 | [Slow channel syndrome due to an autosomal translocation at 2q31-9p27]. ( Crielaard, JM; Hansen, I; Wang, FC; Zeevaert, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (81.82) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STUPPLER, A | 1 |
| KLEIN, JJ | 1 |
| GOTTLIEB, AJ | 1 |
| MONES, RJ | 1 |
| APPEL, SH | 1 |
| OSSERMAN, KE | 1 |
| DISTEFANO, R | 1 |
| STERN, GM | 1 |
| HALL, JM | 1 |
| ROBINSON, DC | 1 |
| Johnson, BR | 1 |
| Kim, YI | 1 |
| Sanders, DB | 1 |
| Berman, PW | 1 |
| Patrick, J | 2 |
| Gu, D | 1 |
| Wogensen, L | 1 |
| Calcutt, NA | 1 |
| Xia, C | 1 |
| Zhu, S | 1 |
| Merlie, JP | 1 |
| Fox, HS | 1 |
| Lindstrom, J | 2 |
| Powell, HC | 1 |
| Sarvetnick, N | 1 |
| Shenoy, M | 1 |
| Christadoss, P | 1 |
| Zeevaert, B | 1 |
| Hansen, I | 1 |
| Crielaard, JM | 1 |
| Wang, FC | 1 |
| Havard, CW | 1 |
| Lange, MJ | 1 |
| Engel, AG | 1 |
| Tsujihata, M | 1 |
| Lindstrom, JM | 2 |
| Lennon, VA | 2 |
| Seybold, ME | 1 |
| Sghirlanzoni, A | 1 |
| Pareyson, D | 1 |
| Benvenuti, C | 1 |
| Cei, G | 1 |
| Cosi, V | 1 |
| Lombardi, M | 1 |
| Nicora, M | 1 |
| Ricciardi, R | 1 |
| Cornelio, F | 1 |
| MacKechnie, HL | 1 |
| Squires, AH | 1 |
| Platts, M | 1 |
| Pruzanski, W | 1 |
| Goldstein, G | 1 |
| Whittingham, S | 1 |
| Meiring, PD | 1 |
| Vetters, JM | 1 |
| Simpson, JA | 1 |
| Folkarde, A | 1 |
| Turner, JW | 1 |
| Bayer, HW | 1 |
| Reismann, B | 1 |
| Harvey, AM | 1 |
| Booker, HE | 1 |
| Chun, RW | 1 |
| Sanguino, M | 1 |
2 reviews available for neostigmine and Autoimmune Disease
| Article | Year |
|---|---|
[Myasthenia gravis].
Topics: Autoimmune Diseases; Cholinesterase Inhibitors; Humans; Myasthenia Gravis; Neostigmine; Physostigmin | 1977 |
President's address. Myasthenia gravis.
Topics: Adrenocorticotropic Hormone; Adult; Age Factors; Aged; Autoimmune Diseases; Blepharoptosis; Diplopia | 1974 |
1 trial available for neostigmine and Autoimmune Disease
| Article | Year |
|---|---|
Efficacy of intranasal administration of neostigmine in myasthenic patients.
Topics: Administration, Intranasal; Aerosols; Autoimmune Diseases; Drug Administration Schedule; Drug Evalua | 1992 |
19 other studies available for neostigmine and Autoimmune Disease
| Article | Year |
|---|---|
[Preliminary results of experimental studies on the myasthenic syndrome].
Topics: Animals; Autoimmune Diseases; Humans; Lambert-Eaton Myasthenic Syndrome; Muscular Diseases; Myasthen | 1953 |
THYMOMA AND POLYMYOSITIS. ONSET OF MYASTHENIA GRAVIS AFTER THYMECTOMY: REPORT OF TWO CASES.
Topics: Aspartate Aminotransferases; Autoimmune Diseases; Biopsy; Cortisone; Electromyography; Humans; Myast | 1964 |
[MYASTHENIC SYNDROMES].
Topics: Atropine; Autoimmune Diseases; Diagnosis; Electromyography; Lambert-Eaton Myasthenic Syndrome; Muscu | 1963 |
NEONATAL MYASTHENIA GRAVIS.
Topics: Autoimmune Diseases; Diagnosis; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal | 1964 |
Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
Topics: Animals; Autoimmune Diseases; Decamethonium Compounds; Disease Models, Animal; Electrophysiology; Mo | 1983 |
Experimental myasthenia gravis. A murine system.
Topics: Acetylcholine; Animals; Antibody Formation; Autoimmune Diseases; Cell Line; Female; Mice; Mice, Inbr | 1980 |
Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.
Topics: Animals; Antigens; Autoimmune Diseases; Behavior, Animal; Humans; Interferon-gamma; Mice; Mice, Inbr | 1995 |
Induction of experimental autoimmune myasthenia gravis with acetylcholine receptors using a nonionic block copolymer as adjuvant.
Topics: Adjuvants, Immunologic; Animals; Antigen-Antibody Complex; Autoantibodies; Autoantigens; Autoimmune | 1993 |
[Slow channel syndrome due to an autosomal translocation at 2q31-9p27].
Topics: Action Potentials; Adult; Autoimmune Diseases; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair | 2002 |
The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
Topics: Animals; Autoimmune Diseases; Cholinesterase Inhibitors; Disease Models, Animal; Female; Freund's Ad | 1976 |
Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.
Topics: Acetylcholine; Animals; Autoantibodies; Autoimmune Diseases; Body Weight; Disease Models, Animal; El | 1975 |
Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient.
Topics: Ambenonium Chloride; Anemia, Aplastic; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Bronchop | 1973 |
Experimental autoimmune thymitis. An animal model of human myasthenia gravis.
Topics: Animals; Autoimmune Diseases; Electromyography; Freund's Adjuvant; Guinea Pigs; Lymphocytes; Myasthe | 1966 |
Association between hypothyroidism and myasthenia gravis and a concept of generalized systemic auto-immunopathy.
Topics: Autoimmune Diseases; Beta-Globulins; Female; gamma-Globulins; Humans; Hypertension; Hypothyroidism; | 1967 |
Experimental myasthenia gravis.
Topics: Animals; Antigens; Autoimmune Diseases; Electromyography; Freund's Adjuvant; Guinea Pigs; Muscles; M | 1969 |
Autoimmune response to acetylcholine receptor.
Topics: Animals; Antibody Formation; Antigens; Autoimmune Diseases; Edrophonium; Eels; Electric Organ; Elect | 1973 |
[Therapy of thymus neoplasms and of myasthenia gravis pseudoparalytica].
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Female; Humans; Male; Middle Aged; Myasthenia Gravis; | 1973 |
Myasthenia gravis--the first 100 years in perspective.
Topics: Acetylcholine; Animals; Autoimmune Diseases; Electromyography; History, 19th Century; History, 20th | 1971 |
Myasthenia gravis syndrome associated with trimethadione.
Topics: Anticonvulsants; Autoimmune Diseases; Child; Drug Hypersensitivity; Epilepsy, Absence; Female; Human | 1970 |